无全反应性CAR-VST疗法:在病毒背景下长期瘤控制方面迈出了一步
Valentine Wang1, Barbara Savoldo2, José-Arthur Guimaraes1
1Unité Mixte de Recherche (UMR) 7365 Centre National de la Recherche Scientifique (CNRS), Ingénierie Moléculaire, Cellulaire et Physiopathologie (IMoPA), Université de Lorraine, Nancy, France.
Frontiers in immunology
|January 30, 2025
概括
病毒特异性T细胞 (CAR-VSTs) 为全源CAR-T细胞疗法提供了一个有前途的解决方案,克服了免疫排斥和移植对宿主疾病等挑战,以提高持久性和疗效.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法 细胞疗法
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法改变了免疫疗法,但在全基应用中面临重大障碍,包括移植排斥和移植对宿主疾病.
- 与CARs (CAR-VSTs) 进行工程的病毒特异性T细胞 (VSTs) 显示出克服这些局限性的潜力,提供增强的持久性和抗瘤活性.
研究的目的:
- 提供对CAR-VST开发用于全源免疫疗法的全面审查.
- 突出减轻免疫性和改善治疗持久性的策略.
- 探索CAR-VST的潜力,以应对与传统CAR-T疗法相关的挑战.
主要方法:
- 审查关于CAR-VST开发,生产和优化的现有文献.
- 分析增强CAR-VST功能的策略,包括专门的TCR使用,激活,记忆持久性和耐耗性.
- 检查CAR-VSTs的临床前和临床结果.
主要成果:
- CAR-VST在异构环境中显示出增强持久性和抗瘤疗效的潜力.
- 现有策略可以减轻免疫性并改善对宿主免疫反应的抵抗力.
- CAR-VST对抗瘤和抗病毒反应具有双重特异性.
结论:
- 与传统的CAR-T细胞相比,CAR-VST代表了一项有前途的进步,用于全源免疫疗法.
- 优化策略可以提高CAR-VST的功能,有效性和耐用性.
- 在治疗各种疾病方面,CAR-VST为广泛的临床应用提供了新的视角.
相关概念视频
01:27Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:30Cancer Vaccines
330
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
330
01:10Retrovirus Life Cycles
45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K